大麻二醇在症中的多面性标:调节谷氨酸信号传递和超越
Pukar Khanal1, Vishal S Patil2, Kunal Bhattacharya3
1KLE College of Pharmacy Belagavi, KLE Academy of Higher Education and Research (KAHER), Belagavi, 590010, India; Silicon Script Sciences Private Limited, Bharatpur, Ghorahi, Dang, Nepal.
Computers in biology and medicine
|July 24, 2024
概括
大麻素 (CBD) 可能通过与谷氨酸受体直接相互作用来治疗. 这项研究确定了CBD的CBD.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 大麻 (CBD) 具有广泛的生物活性,包括潜在的抗作用,但其确切的机制尚不清楚.
- 虽然建议CBD对谷氨酸信号传递的影响,但缺乏直接证据将CBD与中谷氨酸信号传递联系起来.
研究的目的:
- 为了确定与有关的大麻素 (CBD) 标.
- 为了评估CBD治疗后的基因表达变化.
- 为了研究CBD和的谷氨基基信号通路之间的潜在直接相互作用.
主要方法:
- 使用了Tanimoto系数和相似性指数,用于针对CBD与相关蛋白质的目标捕捞.
- 集成的目标数据与基因表达特征,的生物标志物和遗传改变.
- 采用分子对接和模拟 (AutoDock Vina,GROMACS) 来分析结合亲和力和稳定性.
主要成果:
- 在各种蛋白质类中确定了30个与相关的CBD标.
- 发现谷氨酸受体2作为的基因改变目标,通过CBD治疗调节.
- 证明了CBD与谷氨酸受体2的直接结合亲和力,显示了稳定的相互作用和有利的生物物理特性.
结论:
- 大麻二醇 (CBD) 可能通过直接调节谷氨酸受体2产生抗作用.
- 研究结果表明,CBD在症中的作用具有特定的分子机制,涉及谷氨酸基途径.
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
310
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
310
Antiepileptic Drugs: GABAergic Pathway Potentiators
371
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
371
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
279
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
279
Antiepileptic Drugs: Potassium Channel Activators
158
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
158
Arteries of the Lower Limbs
182
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
182
Antiepileptic Drugs: Calcium Channel Blockers
357
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
357


